Search

everythinglearnresearchcommunity

for

Search:↓

Methotrexate and azathioprine are equally effective and well-tolerated for treating lichen planopilaris.

Aging and chronic inflammation weaken the immune system, increasing cancer and infection risks.

Transcranial electrical stimulation may help reduce certain immune markers in COVID-19 patients.

DHT may reduce inflammation caused by certain bacteria in skin cells.

Selective immunotherapies like anifrolumab and belimumab are more effective for treating systemic lupus erythematosus than traditional drugs.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

The guidelines suggest a detailed approach to diagnosing and treating lupus, with a focus on regular check-ups, personalized medicine, and a range of drug options for different cases.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

Transplant success has improved with better immunosuppressive drugs and donor matching.

UVB exposure in human skin causes macrophages to produce more IL-10 and less IL-12, leading to immunosuppression.

COVID-19 can cause skin issues like rashes and "COVID toes," and people with skin conditions should adjust their treatments if they get the virus.

The document concludes that skin biopsies, genetic and environmental factors, and specific treatments are important in managing cutaneous lupus erythematosus.

A rare skin condition was confirmed to be associated with a specific virus in a young girl.

Treating cystoid macular oedema in uveitis is difficult and risky.

Contact sensitizers like DCP and SADBE are the most effective treatments for alopecia areata.

Majocchi's granuloma can occur in kidney transplant patients on tacrolimus and can be treated with antifungal medication.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Current and future treatments for alopecia areata focus on immunosuppression, immunomodulation, and protecting hair follicles.

More pediatric-specific research and guidelines are needed to improve hidradenitis suppurativa treatment in children and adolescents.

Fungal infections in lab animals can interfere with research.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Two transplant patients on cyclosporine unexpectedly developed hair loss.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

A kidney transplant patient developed pink skin bumps with spiny centers on her face and limbs.

The document says that treating the root cause of hair follicle damage is crucial to prevent permanent hair loss, and treatment options vary.

Nonimmunosuppressive cyclosporines might treat skin diseases by affecting cell growth.

Oclacitinib effectively treated a skin condition in dogs that didn't respond to other immunosuppressants.

Patients with chronic graft-versus-host disease often have skin problems like vitiligo and alopecia areata.

Tacrolimus can cause hair loss in kidney transplant patients.